drugset / Trial / NCT06605703
A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)
RandomizedParallel-groupSingle-blindTreatment
Summary
The study compares the effectiveness of treatment options for weight management after discontinuing semaglutide and tirzepatide. The primary outcome is absolute and percentage weight change at 12-weeks.
Timeline
- Start
- 2024-09-18
- Primary completion
- 2026-02-05
- Completion
- 2026-02-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | — | — |
| Subject | Metformin | Small molecule | — | — |
| Subject | Naltrexone | Small molecule | — | — |